{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:26:59Z","timestamp":1759638419054,"version":"3.44.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jhep.2022.11.016","type":"journal-article","created":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T07:49:29Z","timestamp":1669276169000},"page":"e95-e96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unmasking a hepatitis C genotype 3a\/1b dual infection in an individual treated with elbasvir\/grazoprevir"],"prefix":"10.1016","volume":"78","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7040-5447","authenticated-orcid":false,"given":"Rob W.","family":"van der Pluijm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loek P.","family":"Smits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sjoerd P.","family":"Rebers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1112-0644","authenticated-orcid":false,"given":"Janke","family":"Schinkel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8290-6425","authenticated-orcid":false,"given":"Marc","family":"van der Valk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"journal-title":"J\u00a0Hepatol","article-title":"EASL recommendations on treatment of hepatitis C: final update of the series\u2606","year":"2020","key":"10.1016\/j.jhep.2022.11.016_bib1"},{"key":"10.1016\/j.jhep.2022.11.016_bib2","article-title":"Infection with multiple hepatitis C virus genotypes detected using commercial tests should be confirmed using next generation sequencing","author":"Fern\u00e1ndez-Caso","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jhep.2022.11.016_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.02366-06","article-title":"Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C\/E1 and 5\u2032 untranslated region sequences","author":"Murphy","year":"2007","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.jhep.2022.11.016_bib4","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01620-17","article-title":"In\u00a0vitro antiviral activity and resistance profile of the next-generation hepatitis C virus NS3\/4A protease inhibitor glecaprevir","author":"Ng","year":"2018","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822033104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827822033104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T19:47:46Z","timestamp":1759175266000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827822033104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S0168827822033104"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2022.11.016","relation":{},"ISSN":["0168-8278"],"issn-type":[{"type":"print","value":"0168-8278"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmasking a hepatitis C genotype 3a\/1b dual infection in an individual treated with elbasvir\/grazoprevir","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2022.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}